Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories International Inc. (CRL) shares rose 3.56% to $277.00, outperforming competitors and broader market indices on a grim trading day. This marks the stock's fifth consecutive gain, hitting a new 52-week high above its previous peak of $268.00. Trading volume exceeded its 50-day average, while peers like Labcorp saw modest gains and others declined.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) rallied 3.56% to $277.00 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
This was the stock's fifth consecutive day of gains.
Charles River Laboratories International Inc. hit a new 52-week high, surpassing its previous peak of $268.00, which the company reached on August 6th.
The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 0.67% to $321.31, Alnylam Pharmaceuticals Inc. (ALNY) fell 1.01% to $216.98, and Bio-Techne Corp. (TECH) fell 0.24% to $72.12.
Trading volume (1.0 M) eclipsed its 50-day average volume of 882,240.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1716ET